Given the pivotal role of IFN-I signaling in tumor immunity, a natural bioactive chemical library was screened (Selleck L1400) using an IFN-β-Luc reporter assay to identify potential IFN-I inducers (Fig. 1A). The gene discussed is IFNB1; the disease is neoplasm.